Markets

Market

News Details

(27/04/2026 10:22)

Sun Pharma to acquire Organon & Co in USD 11.75 billion deal

Sun Pharmaceutical Industries Ltd has announced the acquisition of US-based Organon & Co in an all-cash transaction, valuing the deal at an enterprise value of USD 11.75 billion—one of the largest overseas acquisitions by an Indian company.

Under a definitive agreement, Sun Pharma will acquire all outstanding shares of Organon at USD 14 per share in a fully cash-based deal, the company said in a statement on Monday.

Organon, a global healthcare firm, was spun off from Merck & Co. (known as MSD outside the US and Canada) in 2021. The company operates six manufacturing facilities across the European Union and other emerging markets.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.